Source:http://linkedlifedata.com/resource/pubmed/id/11443769
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12 Suppl
|
pubmed:dateCreated |
2001-7-10
|
pubmed:abstractText |
There is presently much debate about the optimal flow chart of pre-end-stage renal disease (ESRD) and ESRD patients. This article summarizes two important nonmedical factors that affect the outcome of ESRD patients in Europe: late referral and the structure of the health care system. In a European survey, 30% of patients were referred to a nephrologist less than 1 mo before the start of renal replacement therapy (RRT). This had an impact on the modality choice, as 77.5% of late versus 51.1% of early referrals were started on hemodialysis. Hospitalization at start of RRT was longer in late versus early referrals (15.1 +/- 16.0 versus 27.8 +/- 23.7 d respectively, P < 0.001). There were more patients without antihypertensive medication in the late referral group (28.6% versus 15.5%, P = 0.004), and diastolic BP in this group was higher (83.5 +/- 15.8 versus 74.4 +/- 15.0 mmHg, P = 0.03). One year after the start of dialysis, the number of deaths in the late referrals was higher (26.7 versus 16.4%, P = 0.07) and the number of transplanted patients was lower (4.7 versus 17.5%, P = 0.02). Creatinine clearance at start of RRT was 7.0 +/- 3.5 ml/min in the patients who died during the first year after start of RRT versus 9.5 +/- 3.6 ml/min in those surviving. Only 18% of patients were started with a creatinine clearance > 10 ml/min, as recommended by the Dialysis Outcomes Quality Initiative guidelines. It is concluded that late referral to a nephrologist is still a major problem that has a negative influence on modality choice for peritoneal dialysis, and on morbidity and mortality of ESRD patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1046-6673
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S55-62
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11443769-Europe,
pubmed-meshheading:11443769-Health Services Accessibility,
pubmed-meshheading:11443769-Humans,
pubmed-meshheading:11443769-Kidney Failure, Chronic,
pubmed-meshheading:11443769-Quality of Health Care,
pubmed-meshheading:11443769-Referral and Consultation,
pubmed-meshheading:11443769-Renal Replacement Therapy,
pubmed-meshheading:11443769-Risk Factors,
pubmed-meshheading:11443769-Time Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
End-stage renal disease treatment: a European perspective.
|
pubmed:affiliation |
Renal Division, Department of Internal Medicine, University Hospital, Gent, Belgium.
|
pubmed:publicationType |
Journal Article,
Review
|